$65.26
-0.11 (-0.17%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+7.25%
YTD
-14.96%
Open$65.93
Previous Close$65.37
Day High$66.21
Day Low$64.99
52W High$90.87
52W Low$57.74
Volume—
Avg Volume988.5K
Market Cap5.57B
P/E Ratio—
EPS$-0.59
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$75.08
Below
SMA 200
$61.55
Above
RSI (14)
25.1
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
+19.5% upside
Current
$65.26
$65.26
Target
$77.98
$77.98
$54.55
$77.98 avg
$125.35
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.67B | 1.17B | 623.61M |
| Net Income | 658.43M | 414.48M | 103.27M |
| Profit Margin | 39.4% | 37.5% | 16.6% |
| EBITDA | 860.04M | 571.47M | 195.81M |
| Free Cash Flow | — | — | 61.49M |
| Rev Growth | +128.3% | +35.3% | +11.8% |
| Debt/Equity | 0.51 | 848.93 | 0.18 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.73 | +0.29% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $392.34 | +1.73% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $151.59 | +0.99% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $511.29 | +0.58% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $794.14 | +1.18% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.64 | +2.12% | 40.0 | 32.33B |